SCRI — Nashville, Tennessee

SCRI is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Clinical Trials Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

SCRI has participated in 14 clinical trials with 1 currently active.

Therapeutic areas: Bladder Cancer, Squamous Cell Carcinoma of the Lung, Esophageal Squamous Cell Carcinoma.

Sponsors: EvolveImmune United, Inc, Celgene, SCRI Development Innovations, LLC.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI?

SCRI has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI conducted?

SCRI has 14 clinical trials on record, with 1 currently active. Their work covers Bladder Cancer, Squamous Cell Carcinoma of the Lung, Esophageal Squamous Cell Carcinoma.

Is SCRI accredited by Crixeo Clinical Trials?

SCRI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.